Skip to content
About us
Solution
Resources
Investors
Newsroom
Contact
Rights Issue 2025
About us
Solution
Resources
Investors
Newsroom
Contact
Rights Issue 2025
SV
EN
Newsroom
Presentations
Analyses
Lumito in the media
Media bank
Newsletter
Newsroom
Presentations
Analyses
Lumito in the media
Media bank
Newsletter
Newsroom
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2025
2025-10-23 08:30
Lumito AB and Katana Labs GmbH sign Letter of Intent and enter into a strategic partnership to enhance biomarker detection and quantification
Regulatory
2025-10-22 18:00
Investor presentation from Financial Stockholm is now available
Regulatory
2025-10-17 13:15
Lumito presents at Financial Stockholm on the 21st of October
Regulatory
2025-10-16 08:30
The subscription period in Lumito’s rights issue of units starts today
Regulatory
2025-10-15 12:00
Concept Life Sciences adds Lumito's tissue analysis solution to its customer offering following positive results from the SCIZYS platform evaluation
Regulatory
2025-10-13 11:50
Lumito AB publishes prospectus in connection with rights issue of units of approximately SEK 60 million
Regulatory
2025-10-07 08:00
Lumito AB announces terms of rights issue of units of approximately SEK 60 million
Regulatory
2025-10-03 15:10
Lumito AB publishes white paper on the use of SCIZYS for high-sensitivity analysis of the breast cancer biomarker HER2 in tissue
Regulatory
2025-10-02 11:45
Lumito AB at Biomarkers & Precision Medicine UK, NLSDays and Pharma Outsourcing
Regulatory
2025-09-18 14:50
Lumito Selected for Business Sweden’s CATALYST 2025 – Focusing on Expansion in the United Kingdom
Regulatory
Next